Surface plasmon resonance analysis of antipolysaccharide antibody specificity: Responses to meningococcal group C conjugate vaccines and bacteria

Infection and Immunity

Volumn 72, Issue 6, 2004, Pages 3451-3460

  García Ojeda, Pablo A ^a   Hardy, Sharon ^b   Kozlowski, Steven ^a   Stein, Kathryn E ^a,c   Feavers, Ian M ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c Analytical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; DIPHTHERIA TOXIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; MENINGOCOCCAL GROUP C POLYSACCHARIDE VACCINE; TETANUS TOXOID; THYMUS INDEPENDENT ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACTERIAL VIRULENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACETYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; SURFACE PLASMON RESONANCE;

ACETYLATION; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; SURFACE PLASMON RESONANCE;

EID: 2542631306     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.6.3451-3460.2004     Document Type: Article

References (66)

1. Adams, W. G., K. A. Deaver, S. L. Cochi, B. D. Plikaytis, E. R. Zell, C. V. Broome, and J. D. Wenger. 1993. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 269:221-226.
2. Ahlstedt, S., J. Holmgren, and L. A. Hanson. 1974. Protective capacity of antibodies against E. coli O antigen with special reference to the avidity. Int. Arch. Allergy Appl. Immunol. 46:470-480.
3. Altschuh, D., M. C. Dubs, E. Weiss, G. Zeder-Lutz, and M. H. Van Regenmortel. 1992. Determination of kinetic constants for the interaction between a monoclonal antibody and peptides using surface plasmon resonance. Biochemistry 31:6298-6304.
4. Anderson, E. L., T. Bowers, C. M. Mink, D. J. Kennedy, R. B. Belshe, H. Harakeh, L. Pais, P. Holder, and G. M. Carlone. 1994. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect. Immun. 62:3391-3395.
5. Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786.
6. Arakere, G., and C. E. Frasch. 1991. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers. Infect. Immun. 59:4349-4356.
7. Avery, O. T., and W. F. Goebel. 1931. Chemo-immunological studies on conjugated carbohydrate-proteins. V. The immunological specificity of an antigen prepared by combining the capsular polysaccharide of type III pneumococcus with foreign protein. J. Exp. Med. 54:437-447.
8. Barbour, M. L. 1996. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg. Infect. Dis. 2:176-182.
9. Beuvery, E. C., R. W. van Delft, F. Miedema, V. Kanhai, and J. Nagel. 1983. Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice. Infect. Immun. 41:609-617.
10. Bhattacharjee, A. K., H. J. Jennings, C. P. Kenny, A. Martin, and I. C. P. Smith. 1975. Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance. J. Biol. Chem. 250:1926-1932.
11. Borrebaeck, C. A., A. C. Malmborg, C. Furebring, A. Michaelsson, S. Ward, L. Danielsson, and M. Ohlin. 1992. Kinetic analysis of recombinant antibody-antigen interactions: relation between structural domains and antigen binding. Bio/Technology 10:697-698.
12. Borrow, R., E. Longworth, S. J. Gray, and E. B. Kaczmarski. 2000. Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom. FEMS Immunol. Med. Microbiol. 28:189-191.
13. Borrow, R., P. Richmond, E. B. Kaczmarski, A. Iverson, S. L. Martin, J. Findlow, M. Acuna, E. Longworth, R. O'Connor, J. Paul, and E. Miller. 2000. Meningococcal serogroup C-specific IgG antibody responses and serum bactericidal titres in children following vaccination with a meningococcal A/C polysaccharide vaccine. FEMS Immunol. Med. Microbiol. 28:79-85.
14. Borrow, R., J. Southern, N. Andrews, N. Peake, R. Rahim, M. Acuna, S. Martin, E. Miller, and E. Kaczmarski. 2001. Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naive controls. Vaccine 19:3043-3050.
15. Ceesay, S. J., S. J. Allen, A. Menon, J. E. Todd, K. Cham, G. M. Carlone, S. H. Turner, L. L. Gheesling, W. DeWitt, B. D. Plikaytis, and B. Greenwood. 1993. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J. Infect. Dis. 167:1212-1216.
16. Centers for Disease Control and Prevention. 1999. Impact of vaccines universally recommended for children - United States, 1990-1998. Morb. Mortal. Wkly. Rep. 48:243-248.
17. Cooper, L. J., D. Robertson, R. Granzow, and N. S. Greenspan. 1994. Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance. Mol. Immunol. 31:577-584.
18. Costantino, P., S. Viti, A. Podda, M. A. Velmonte, L. Nencioni, and R. Rappuoli. 1992. Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine 10:691-698.
19. Douglas, R. M., J. C. Paton, S. J. Duncan, and D. J. Hansman. 1983. Antibody response to pneumococcal vaccination in children younger than five years of age. J. Infect. Dis. 148:131-137.
20. 13C NMR spectroscopy, p. 197. In J. S. Cohen (ed.), Magnetic resonance in biology, vol. 1. John Wiley & Sons, New York, N.Y.
21. Fairley, C. K., N. Begg, R. Borrow, A. J. Fox, D. M. Jones, and K. Cartwright. 1996. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J. Infect. Dis. 174:1360-1363.
22. Ferson, M., L. Young, G. Hansen, J. Post, J. Tapsall, T. Shultz, A. Limnios, D. Lee, P. Reinbott, Y. Duffy, P. Robertson, P. Jones, G. Pontivivo, and K. Morgan. 1999. Unusual cluster of mild invasive serogroup C meningococcal infection in a university college. Commun. Dis. Intell. 23:261-264.
23. Garcia-Ojeda, P. A., M. E. Monser, L. J. Rubinstein, H. J. Jennings, and K. E. Stein. 2000. Murine immune response to Neisseria meningitidis group C capsular polysaccharide: analysis of monoclonal antibodies generated in response to a thymus-independent antigen and a thymus-dependent toxoid conjugate vaccine. Infect. Immun. 68:239-246.
24. Gilmore, A., G. Jones, M. Barker, N. Soltanpoor, and J. M. Stuart. 1999. Meningococcal disease at the University of Southampton: outbreak investigation. Epidemiol. Infect. 123:185-192.
25. Glode, M. P., E. B. Lewin, A. Sutton, C. T. Le, E. C. Gotschlich, and J. B. Robbins. 1979. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers. J. Infect. Dis. 139:52-59.
26. Gold, R., M. L. Lepow, I. Goldschneider, T. F. Draper, and E. C. Gotshlich. 1979. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J. Infect. Dis. 140:690-697.
27. Gold, R., M. L. Lepow, I. Goldschneider, T. L. Draper, and E. C. Gotschlich. 1975. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J. Clin. Investig. 56:1536-1547.
28. Gold, R., M. L. Lepow, I. Goldschneider, and E. C. Gotschlich. 1977. Immune response of human infants to polysaccharide vaccines of group A and C Neisseria meningitidis. J. Infect. Dis. 136(Suppl.):S31-S35.
29. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
30. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. II. Development of natural immunity. J. Exp. Med. 129:1327-1348.
31. Gotschlich, E. C., I. Goldschneider, and M. S. Artenstein. 1969. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J. Exp. Med. 129:1367-1384.
32. Granoff, D. M., S. E. Maslanka, G. M. Carlone, B. D. Plikaytis, G. F. Santos, A. Mokatrin, and H. V. Raff. 1998. A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin. Diagn. Lab. Immunol. 5:479-485.
33. Harrison, L. H., D. M. Dwyer, C. T. Maples, and L. Billmann. 1999. Risk of meningococcal infection in college students. JAMA 281:1906-1910.
34. Hutchinson, A. M. 1994. Characterization of glycoprotein oligosaccharides using surface plasmon resonance. Anal. Biochem. 220:303-307.
35. Jennings, H. J., and C. Lugowski. 1981. Immunochemistry of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127:1011-1018.
36. Jodar, L., I. M. Feavers, D. Salisbury, and D. M. Granoff. 2002. Development of vaccines against meningococcal disease. Lancet 359:1499-1508.
37. Jonsson, U., L. Fagerstam, B. Ivarsson, B. Johnsson, R. Karlsson, K. Lundh, S. Lofas, B. Persson, H. Roos, I. Ronnberg, et al. 1991. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. BioTechniques 11:620-627.
38. Joseph, H., E. Miller, M. Dawson, N. Andrews, I. Feavers, and R. Borrow. 2001. Meningococcal serogroup A avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom. J. Infect. Dis. 184:661-662.
39. Karlsson, R., A. Michaelsson, and L. Mattsson. 1991. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods 145:229-240.
40. Leach, A., P. A. Twumasi, S. Kumah, W. S. Banya, S. Jaffar, B. D. Forrest, D. M. Granoff, D. E. LiButti, G. M. Carlone, L. B. Pais, C. V. Broome, and B. M. Greenwood. 1997. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J. Infect. Dis. 175:200-204.
41. Lepow, M. L., I. Goldschneider, R. Gold, M. Randolph, and E. C. Gotschlich. 1977. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics 60:673-680.
42. Lieberman, J. M., S. S. Chiu, V. K. Wong, S. Partidge, S. J. Chang, C. Y. Chiu, L. L. Gheesling, G. M. Carlone, and J. I. Ward. 1996. Safety and immunogenicity of a serogroup A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial. JAMA 275:1499-1503.
43. MacDonald, N. E., S. A. Halperin, B. J. Law, B. Forrest, L. E. Danzig, and D. M. Granoff. 1998. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA 280:1685-1689.
44. Mayer, L. W., M. W. Reeves, N. Al-Hamdan, C. T. Sacchi, M. K. Taha, G. W. Ajello, S. E. Schmink, C. A. Noble, M. L. Tondella, A. M. Whitney, Y. Al-Mazrou, M. Al-Jefri, A. Mishkhis, S. Sabban, D. A. Caugant, J. Lingappa, N. E. Rosenstein, and T. Popovic. 2002. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J. Infect. Dis. 185:1596-1605.
45. Michon, F., C. H. Huang, E. K. Farley, L. Hronowski, J. Di, and P. C. Fusco. 2000. Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Dev. Biol. 103:151-160.
46. Mosier, D. E., I. M. Zitron, J. J. Mond, A. Ahmed, I. Scher, and W. E. Paul. 1977. Surface immunoglobulin D as a functional receptor for a subclass of B lymphocytes. Immunol. Rev. 37:89-104.
47. Murphy, T. V., K. E. White, P. Pastor, L. Gabriel, F. Medley, D. M. Granoff, and M. T. Osterholm. 1993. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 269:246-248.
48. Ouchterlony, O. 1958. Diffusion-in-gel methods for immunological analysis. Prog. Allergy 51:1-78.
49. Peltola, H., H. Kayhty, A. Sivonen, and H. Makela. 1977. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 60:730-737.
50. Perlmutter, R. M., D. Hansburg, D. E. Briles, R. A. Nicolotti, and J. M. Davie. 1978. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:566-572.
51. Ramsay, M. E., N. Andrews, E. B. Kaczmarski, and E. Miller. 2001. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 357:195-196.
52. Richmond, P., R. Borrow, J. Findlow, S. Martin, C. Thornton, K. Cartwright, and E. Miller. 2001. Evaluation of de-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and de-O-acetylated serogroup C strains. Infect. Immun. 69:2378-2382.
53. Richmond, P., R. Borrow, E. Miller, S. Clark, F. Sadler, A. Fox, N. Begg, R. Morris, and K. Cartwright. 1999. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J. Infect. Dis. 179:1569-1572.
54. Rubinstein, L. J., P. A. Garcia-Ojeda, F. Michon, H. J. Jennings, and K. E. Stein. 1998. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine. Infect. Immun. 66:5450-5456.
55. Rubinstein, L. J., and K. E. Stein. 1988. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. I. Ontogeny. J. Immunol. 141:4352-4356.
56. Rubinstein, L. J., and K. E. Stein. 1988. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity. J. Immunol. 141:4357-4362.
57. Salisbury, D. 2001. Introduction of a conjugate meningococcal type C vaccine programme in the UK. J. Paediatr. Child Health 37:S34-S37.
58. Sell, S. H., P. F. Wright, W. K. Vaughn, J. Thompson, and G. Schiffman. 1981. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev. Infect. Dis. 3(Suppl.):S97-S107.
59. Stein, K. E. 1992. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J. Infect. Dis. 165(Suppl. 1):S49-S52.
60. Stein, K. E., D. A. Zopf, B. M. Johnson, C. B. Miller, and W. E. Paul. 1982. The immune response to an isomaltohexosyl-protein conjugate, a thymus-dependent analogue of alpha(1 replaced by 6) dextran. J. Immunol. 128:1350-1354.
61. Stein, K. E., D. A. Zopf, C. B. Miller, B. M. Johnson, P. K. Mongini, A. Ahmed, and W. E. Paul. 1983. Immune response to a thymus-dependent form of B512 dextran requires the presence of Lyb-5+ lymphocytes. J. Exp. Med. 157:657-666.
62. Steinhoff, M. C. 1997. Haemophilus influenzae type b infections are preventable everywhere. Lancet 349:1186-1187.
63. Steward, M. W., and A. M. Lew. 1985. The importance of antibody affinity in the performance of immunoassays for antibody. J. Immunol. Methods 78:173-190.
64. Swanson, S. J., D. Mytych, and J. Ferbas. 2002. Use of biosensors to monitor the immune response. Dev. Biol. 109:71-78.
65. Twumasi, P. A., Jr., S. Kumah, A. Leach, T. J. O'Dempsey, S. J. Ceesay, J. Todd, C. V. Broome, G. M. Carlone, L. B. Pais, P. K. Holder, B. D. Plikaytis, and B. M. Greenwood. 1995. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J. Infect. Dis. 171:632-638.
66. Zeder-Lutz, G., D. Altschuh, H. M. Geysen, E. Trifilieff, G. Sommermeyer, and M. H. Van Regenmortel. 1993. Monoclonal antipeptide antibodies: affinity and kinetic rate constants measured for the peptide and the cognate protein using a biosensor technology. Mol. Immunol. 30:145-155.